Verastem, Inc. — Investor Relations & Filings
Verastem, Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for cancer patients. The company concentrates on targeting the RAS/MAPK signaling pathway, which is associated with numerous aggressive and recurrent cancers. Its clinical program utilizes novel small molecule inhibitors and combination therapies. Verastem has achieved a significant milestone with the FDA approval of its combination therapy, the first treatment specifically for patients with recurrent low-grade serous ovarian cancer (LGSOC) harboring a KRAS mutation. The company's mission is to address urgent medical needs by developing innovative treatments for cancers driven by the RAS/MAPK pathway.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 - Verastem, Inc. (0001526119) (Issuer) | 2026-03-23 | English | |
| 8-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | |
| 10-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| SCHEDULE 13G Filing | 2026-02-17 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 33016560 | 4 - Verastem, Inc. (0001526119) (Issuer) | 2026-03-23 | English | ||
| 32893357 | 8-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | ||
| 32893358 | 10-K - VERASTEM, INC. (0001526119) (Filer) | 2026-03-04 | English | ||
| 30355410 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30355407 | SCHEDULE 13G Filing | 2026-02-17 | English | ||
| 30355402 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30355401 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 30355427 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 32893356 | 4 - VERASTEM, INC. (0001526119) (Filer) | 2026-02-05 | English | ||
| 30355479 | 8-K Filing | 2026-02-04 | English | ||
| 30355462 | 4 Filing | 2026-01-23 | English | ||
| 30355403 | 4 Filing | 2026-01-23 | English | ||
| 30355399 | 4 Filing | 2026-01-14 | English | ||
| 30355396 | 4 Filing | 2026-01-14 | English | ||
| 12467337 | FORM 8-K | 2026-01-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Verastem, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32713/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32713 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32713 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32713 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32713}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Verastem, Inc. (id: 32713)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.